Ibuprofen vs celecoxib

n=13,274; celecoxib was compared with naproxen and diclofenac) and CLASS (the Celecoxib ibuprofen or diclofenac in CLASS (0.5% vs. 0.3

The primary outcome, incidence of cardiovascular death, myocardial infarction, or stroke, occurred in 2.3% of the celecoxib group vs. 2.7% of the ibuprofen group vs. 2.5% of the naproxen group (hazard ratio [HR] 0.85, p noninferiority 0.001 for celecoxib vs. ibuprofen; HR 0.93, p noninferiority 0.001 for celecoxib vs. naproxen; HR 1.08, p

Celecoxib Integrated Safety vs Ibuprofen Or with celecoxib a cyclooxigenase-2 specific inhibitor, versus ibuprofen or diclofenac.

by ND Yeomans Cited by 61Celecoxib vs Ibuprofen. Celecoxib vs Naproxen. Ibuprofen vs Naproxen. Outcome n (%), n per 100 patient years. Celecoxib. N = 8072. Ibuprofen. N= 8040. Naproxen.

Celecoxib vs Meloxicam. Celecoxib vs Ibuprofen. Celecoxib vs Naproxen. Celecoxib vs Diclofenac. Celecoxib vs Ketorolac. Celecoxib vs Acetaminophen. ROR. NS.

Of note, at Month 4, clinic SBP increased by 5.2 1.41 mmHg in the ibuprofen group, by 3.2 1.41 in the naproxen group and by 1.0 1.41 mmHg in celecoxib patients; (P = 0.007 for the ibuprofen vs. celecoxib comparison and P = 0.17 for the celecoxib vs. naproxen comparison).

For patients who did not titrate, P-values for mean change in 24-h SBP were 0.002, 0.51, 0.04 for celecoxib vs. ibuprofen, celecoxib vs. naproxen, and naproxen vs. ibuprofen respectively. Open in a separate window

Compare Celecoxib vs Etodolac head-to-head with other drugs for uses, ratings, cost, side effects and interactions. Celecoxib vs ibuprofen; 400 mg: Per Unit

naproxen; celecoxib vs. ibuprofen) and non-significant differences (ibuprofen vs. naproxen) were observed in a manner consistent with the data